Area of research
Cancer Research · Oncology
Research interest
Research interests include Medicine, Cancer research, Immunotherapy, Internal medicine, Oncology, and Biology.
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung Cancer
A diverse landscape of FGFR alterations and co-mutations defines novel therapeutic strategies in pediatric low-grade gliomas
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations
Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non–Small-Cell Lung Cancer
PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma
Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness